Who invested in STARR Life Sciences

4 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Healthcare

Funding summaryUpdated 26 Oct 2026

$7.4Mraised across 4 rounds since 2006, from 4 sources

$1.4MVenture$1.8MDebt$3.7MVenture$520KDebt

Latest round: Debt, $520KJul 2011
Biggest round: $3.7MVenture · Oct 2010
Investors: 1

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20072008200920102011

$1.4MVenture$1.8MDebt$3.7MVenture$520KDebt

First round: Venture, $1.4M
Biggest round: $3.7M
Usual gap between rounds: 13 months

The rounds

Jul 2011
Debt$520K
No investor was named in the report.
Reported by sec.govSEC filing: $520K sold, first sale Oct 2010
Oct 2010
Venture$3.7M
No investor was named in the report.
Reported by sec.govSEC filing: $3.7M sold, first sale Oct 2010
Jan 2008
Debt$1.8M
No investor was named in the report.
Reported by sec.gov
Dec 2006
Venture$1.4M1 new
- Pittsburgh Life Sciences Greenho
Reported by sec.gov

Founders and team

From the SEC filings it signed: 4 on the team.

Daniel BevevinoExecutive Officeri
Eric W. StarrDirector, Promoteri
Michael D. LangExecutive Officer, Directori
Steven D. FultonExecutive Officeri

On the board, as filediChristopher A. BrodmanDonald B. WagnerPatrick B. StewartRobert D. CrouchThomas B. Feroah

Everyone who backed them

Pittsburgh Life Sciences GreenhoAccelerator1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists STARR Life Sciences as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.